Financhill
Back

Corcept Therapeutics Vs. Akebia Therapeutics Industry Stock Comparison

Buy
78

CORT
Corcept Therapeutics

Last Price:
52.14
Seasonality Move:
3.97%
Buy
66

AKBA
Akebia Therapeutics

Last Price:
1.86
Seasonality Move:
32.87%
Buy
78
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy, Sell or Hold?

  • The current Corcept Therapeutics [CORT] share price is $52.14. The Score for CORT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Akebia Therapeutics (AKBA) is a Buy

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.86. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

  • The Corcept Therapeutics share price today is $52.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.85 Buy
Relative Strength Index (14 RSI): 69.17 Buy
Chaikin Money Flow: 1050894 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.47 - 49.11) Buy
Bollinger Bands (100): (31.45 - 44.35) Buy

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 78.3 Buy
Chaikin Money Flow: 2495662 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.29 - 1.67) Buy
Bollinger Bands (100): (1.12 - 1.54) Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.68 Buy
20-day SMA: 47.72 Buy
50-day SMA: 42.79 Buy
200-day SMA: 31.51 Buy
8-day EMA: 49.18 Buy
20-day EMA: 47.59 Buy
50-day EMA: 43.78 Buy
200-day EMA: 34.68 Buy

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.71 Buy
20-day SMA: 1.52 Buy
50-day SMA: 1.44 Buy
200-day SMA: 1.39 Buy
8-day EMA: 1.72 Buy
20-day EMA: 1.58 Buy
50-day EMA: 1.47 Buy
200-day EMA: 1.34 Buy

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.

Corcept Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):